NCT07175792

Brief Summary

The aim of this study is to characterize perceptive abilities in PwMS compared to controls when performing prolonged functional tasks such as walking and repeated standing from a seated position. This study proposes primary and secondary research questions which will be tested in the context of two different newly designed experimental tasks and will be performed in maximum three days. The self-reported beliefs over perceptive abilities and the performance in the experimental perceptive tasks will be compared between persons with multiple sclerosis and an equally sized group of age and gender matched healthy controls. The results of this study may uncover specific deficits in the MS population and will help in defining subgroups of patients with weaker perceptive capacities to gauge their motor performance and therefore in need for tailored interventions additional to the standard practice.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
88

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 9, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

September 16, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2025

Completed
Last Updated

November 19, 2025

Status Verified

September 1, 2025

Enrollment Period

10 months

First QC Date

August 19, 2025

Last Update Submit

November 18, 2025

Conditions

Keywords

Motor PerformanceTask-specificPerceptionMultiple SclerosisWalkingSit-to-standInteoception

Outcome Measures

Primary Outcomes (3)

  • Perceptive Sensitivity

    Ratio between participants' reporting frequency and actual variability in motor performance (e.g., gait and sit-to-stand \[STS\]), referred to as the 'Detection-rate.' Number of pinches is divided by the Coefficient of Variability (in %, of speed or smoothness parameter) in the studied time-window.

    Day 1

  • Detection Accuracy

    Accuracy of detecting naturally occurring variations in self-paced gait and sit-to-stand (STS) performance. Objective change points (events) in speed/smoothness are identified using peak detection algorithms with a predefined threshold to extract only perceptually meaningful speed/smoothness fluctuations. Participants indicate perceived changes using a pinch gesture. A response is classified as correct if it occurs within a ±2-second window of a detected event. Responses outside this window or unmatched with any event are incorrect. Perceptive accuracy is modeled as a binary variable (correct/incorrect) and analyzed using mixed-effects logistic regression to account for repeated measures within subjects.

    Day 1

  • Correspondence Accuracy

    Intra-subject correlation between perceived and actual imposed variations in walking speed or seat height, across different difficulty levels. Pearson correlations will study the linear relationship between the exercise difficulty and the reported difficulty. A Fisher Z transformation is carried out on all correlations before further analysis (group level comparisons across participants). -Detailed Picture of Each Phase: Average exercise difficulty and reported difficulty are calculated for every 30 s (or 3 STS repetitions). Multiple mixed model analyses are performed on the phases separately, with exercise difficulty and reported difficulty as dependent variables in separate analyses. Group (patient versus controls) and time are used as independent variables in all analyses. To control for potential baseline differences in any of the outcome variables exercise and reported difficulty in the last 30 s of the baseline phase are added as covariates in the analyses.

    Day 2

Secondary Outcomes (6)

  • Confidence Rating

    Day 1 and 2

  • Perceptive Awareness

    Day 1 and 2

  • Interoceptive Sensibility

    Day 1

  • Proprioceptive Sensibility

    Day 1

  • Interoceptive Sensitivity and Attention Questionnaire (ISAQ)

    Day 1

  • +1 more secondary outcomes

Other Outcomes (28)

  • Visual Analogic Scale for Fatigue

    Day 1 and 2

  • Hospital Anxiety and Depression Scale (HADS)

    Day 1

  • Positive and Negative Affect Schedule (PANAS)

    Day 1

  • +25 more other outcomes

Study Arms (2)

Subjects with Multiple Sclerosis

Inclusion criteria: Age between 18 and 70 years old; a diagnosis of MS (2017 revisions of the McDonalds criteria); ability to walk for 6 minutes without rest and without the need of a walking aid; ability to repeatedly perform the sit to stand transitions on a standard chair (43cm seat height) without hand support. Additionally, no relapses \>1 month preceding the start of the study. Exclusion criteria: cognitive impairment hindering understanding of study instructions, pregnancy, and musculoskeletal disorders in the lower limbs (not related to MS), cardiovascular red flags for exercise (screened with Physical Activity Readines Questionnaire), other diagnosis for neurological or metabolic disease limiting the full execution of the tests (eg. peripheral neuropathy altering the foot plantar sensibility).

Healthy Controls

Age and sex matching is ensured within a five-year range per Healthy Contol. Exclusion criteria: cognitive impairment hindering understanding of study instructions, pregnancy, and musculoskeletal disorders in the lower limbs, cardiovascular red flags for exercise (screened with Physical Activity Readines Questionnaire), other diagnosis for neurological or metabolic disease limiting the full execution of the tests (eg. peripheral neuropathy altering the foot plantar sensibility).

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

44 PwMS and 44 healthy controls will be recruited from the Flemish MS rehabilitation centers in Melsbroek (NMSC) and Pelt (Noorderhart RMSC), and as well from the REVAL research center in UHasselt. No economical compensation will be provided. We will search age and sex-matching healthy controls, considering a 5-year range per subject. After giving informed consent, demographics of age and gender, height and weight, years of education, as well as MS-related information such as EDSS, type of MS, use of assistive device for walking in daily life, and year of diagnosis, will be collected and provided by the centers or via self-report. The participants will be instructed to keep their normal routine but to avoid extraneous physical activity at least 24 hours before the data collection session.

You may qualify if:

  • age between 18 and 70 years old
  • ability to walk for 6 minutes without rest and without the need of a walking aid
  • ability to repeatedly perform the sit to stand transitions on a standard chair (43cm seat height) without hand support
  • For People with Multiple Sclerosis group
  • a diagnosis of MS (2017 revisions of the McDonalds criteria)
  • no disease relapses \>1 month preceding the start of the study

You may not qualify if:

  • cognitive impairment hindering understanding of study instructions
  • ongoing or suspected pregnancy
  • musculoskeletal disorders in the lower limbs
  • cardiovascular red flags for exercise (screened with Physical Activity Readines Questionnaire)
  • other diagnosis for neurological or metabolic disease limiting the full execution of the tests

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

REVAL

Diepenbeek, Belgium, 3590, Belgium

RECRUITING

Noorderhart Revalidatie & MS

Overpelt, Belgium, 3900, Belgium

RECRUITING

Nationaal MS-Centrum Melsbroek

Steenokkerzeel, Belgium, 1820, Belgium

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. dr.

Study Record Dates

First Submitted

August 19, 2025

First Posted

September 16, 2025

Study Start

December 9, 2024

Primary Completion

October 16, 2025

Study Completion

December 9, 2025

Last Updated

November 19, 2025

Record last verified: 2025-09

Locations